# Phase III Cat-PAD Follow-on Study

> **NCT02040844** · PHASE3 · COMPLETED · sponsor: **Circassia Limited** · enrollment: 430 (actual)

## Conditions studied

- Cat Allergy

## Interventions

- **DRUG:** Received Cat-PAD Treatment 1 in Study CP007 [NCT01620762]
- **DRUG:** Received Cat-PAD Treatment 2 in Study CP007 [NCT01620762]
- **DRUG:** Received Cat-PAD Treatment 3 in Study CP007 [NCT01620762]

## Key facts

- **NCT ID:** NCT02040844
- **Lead sponsor:** Circassia Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 430 (ACTUAL)
- **Last updated:** 2018-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02040844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02040844, "Phase III Cat-PAD Follow-on Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02040844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*